PATENT CLAIM ANALYSIS

Application Number: 15933075
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "289000"]

Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claim (Index 22):
The method of  claim 21 , wherein about 105 mg of the bupropion is orally administered twice a day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.45455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15691532', '15164767', '14997316', '15688660', '15695995']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.905176183009934
- 35 USC 102 Novelty (BERT): 0.6487028443832599
- Combined Prediction Score: 0.8795288491472665
- Mean Citation Score: 783.4113140000003
- Max Citation Score: 789.3872700000003
- Similarity Product: 579.341159499178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test